2026

Engineered CCR7 overexpression enhances nodal CAR T-cell homing and cytotoxicity toward B-cell lymphoma.
Zschummel, Maria ORCID: https://orcid.org/0000-0002-4778-8742, Bunse, Mario ORCID: https://orcid.org/0000-0002-7554-2520, Spierling, Anna-Lena ORCID: https://orcid.org/0009-0003-0009-7615, Li, Anna ORCID: https://orcid.org/0000-0002-4702-7783, Joedicke, Jara J. ORCID: https://orcid.org/0000-0002-4708-3216, Margineanu, Anca ORCID: https://orcid.org/0000-0002-6634-9729, Blachut, Susanne ORCID: https://orcid.org/0009-0007-0102-9867, Lindberg, Eric Lars-Helge ORCID: https://orcid.org/0000-0002-2979-433X, Ruiz-Orera, Jorge ORCID: https://orcid.org/0000-0002-8317-0034, Hübner, Norbert ORCID: https://orcid.org/0000-0002-1218-6223, Rehm, Armin ORCID: https://orcid.org/0000-0001-7490-1950 and Höpken, Uta E. ORCID: https://orcid.org/0000-0002-0776-4893
Cancer Immunology Research 14 (5): 827-844. 4 May 2026

2022

Immune phenotypes and target antigens of clonally expanded bone marrow T cells in treatment-naïve multiple myeloma.
Welters, C. ORCID: https://orcid.org/0000-0002-3098-9003, Lammoglia Cobo, M.F. ORCID: https://orcid.org/0000-0002-0369-0364, Stein, C.A. ORCID: https://orcid.org/0000-0002-7892-8007, Hsu, M.T. ORCID: https://orcid.org/0000-0002-5862-4305, Ben Hamza, A. ORCID: https://orcid.org/0000-0003-3021-7406, Penter, L. ORCID: https://orcid.org/0000-0002-9060-0207, Chen, X. ORCID: https://orcid.org/0000-0002-5614-1406, Buccitelli, C. ORCID: https://orcid.org/0000-0001-5865-4961, Popp, O. ORCID: https://orcid.org/0000-0001-6240-4666, Mertins, P. ORCID: https://orcid.org/0000-0002-2245-528X, Dietze, K. ORCID: https://orcid.org/0000-0002-8329-8329, Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Moosmann, A. ORCID: https://orcid.org/0000-0001-8044-5146, Blanc, E. ORCID: https://orcid.org/0000-0002-4369-0254, Beule, D. ORCID: https://orcid.org/0000-0002-3284-0632, Gerbitz, A. ORCID: https://orcid.org/0000-0002-0105-2086, Strobel, J. ORCID: https://orcid.org/0000-0002-1117-0350, Hackstein, H. ORCID: https://orcid.org/0000-0001-9722-8180, Rahn, H.P. ORCID: https://orcid.org/0000-0002-5233-3937, Dornmair, K. ORCID: https://orcid.org/0000-0003-0342-5373, Blankenstein, T. ORCID: https://orcid.org/0000-0002-3357-4321 and Hansmann, L. ORCID: https://orcid.org/0000-0003-3790-0128
Cancer Immunology Research 10 (11): 1407-1419. 1 November 2022

2019

Mapping the MHC class I spliced immunopeptidome of cancer cells.
Liepe, J., Sidney, J., Lorenz, F.K.M. ORCID: https://orcid.org/0000-0001-7826-0839, Sette, A. and Mishto, M.
Cancer Immunology Research 7 (1): 62-76. January 2019

2018

A transgenic dual-luciferase reporter mouse for longitudinal and functional monitoring of T cells in vivo.
Szyska, M. ORCID: https://orcid.org/0000-0002-4213-4600, Herda, S., Althoff, S., Heimann, A., Russ, J., D'Abundo, D., Dang, T.M., Durieux, I., Dörken, B. ORCID: https://orcid.org/0000-0001-7991-3643, Blankenstein, T. ORCID: https://orcid.org/0000-0002-3357-4321 and Na, I.K. ORCID: https://orcid.org/0000-0001-9902-5424
Cancer Immunology Research 6 (1): 110-120. January 2018

2017

Tumor-infiltrating merkel cell polyomavirus-specific T cells are diverse and associated with improved patient survival.
Miller, N.J., Church, C.D., Dong, L., Crispin, D., Fitzgibbon, M.P., Lachance, K., Jing, L., Shinohara, M., Gavvovidis, I. ORCID: https://orcid.org/0000-0001-5644-9788, Willimsky, G. ORCID: https://orcid.org/0000-0002-9693-948X, McIntosh, M., Blankenstein, T. ORCID: https://orcid.org/0000-0002-3357-4321, Koelle, D.M. and Nghiem, P.
Cancer Immunology Research 5 (2): 137-147. February 2017

2015

A rapid embryonic stem cell-based mouse model for B-cell lymphomas driven by Epstein-Barr virus protein LMP1.
Ba, Z., Meng, F.L., Gostissa, M., Huang, P.Y., Ke, Q., Wang, Z., Dao, M.N., Fujiwara, Y., Rajewsky, K. ORCID: https://orcid.org/0000-0002-6633-6370, Zhang, B. and Alt, F.W.
Cancer Immunology Research 3 (6): 641-649. June 2015